BDNF modifies hippocampal KCC2 and NKCC1 expression in a temporal lobe epilepsy model

Area of Science:

• Neuroscience
• Epilepsy Research
• Molecular Biology

Background:

• Excitatory GABAergic actions, driven by altered chloride transporter expression (KCC2/NKCC1), are implicated in temporal lobe epilepsy (TLE) seizure generation.
• Understanding the role of chloride transporters and potential modulators like BDNF is crucial for developing effective TLE treatments.

Purpose of the Study:

• To investigate the effects of BDNF administration on KCC2/NKCC1 expression in a rat model of TLE.
• To evaluate BDNF's impact on seizure development (ictogenesis) and associated behavioral alterations in TLE.

Main Methods:

• Temporal lobe epilepsy was induced in male rats using pilocarpine.
• Rats received either a single high dose or multiple injections of BDNF during the latent phase.
• Chloride transporter expression (KCC2/NKCC1), spontaneous recurrent seizures, and hyperexcitability behaviors were assessed post-treatment.

Main Results:

• Epileptic hippocampi showed upregulated NKCC1 and downregulated KCC2 expression.
• BDNF treatment increased KCC2 expression; a single high dose also downregulated NKCC1.
• BDNF delayed, but did not prevent, spontaneous recurrent seizures and transiently ameliorated hyperexcitability behaviors.

Conclusions:

• Chloride transporters represent a viable target for preventing GABA-A mediated depolarization in TLE.
• BDNF demonstrates potential therapeutic effects by modulating chloride transporters, warranting further investigation for TLE treatment strategies.